Previous proposed updates to the PMPRB Guidelines

This page contains material related to previous proposed versions of the PMPRB Guidelines that no longer apply following the publication of Amendments to the Patented Medicines Regulations.

• New PMPRB Guidelines – The updated Guidelines, set to take effect once the amended Patented Medicines Regulations (“Regulations”) come into Force.
  • Decision resulting from the consultation on the definition of Gap medicines and the timeline for compliance
    • Backgrounder on the Board’s decision
    • Submissions received during the month-long consultation
  • Written response to questions from the House of Commons Standing Committee on Health on November 23 and 27, 2020 (PDF 1.5 MB)
  • Webinars for patentees
    • Online Filing Tool & Transition Measures for Grandfathered and Gap Medicines - June 15, 2021 (PDF 2 MB)
    • Online Filing Tool - Monday, December 7, 2020 (PDF 1.7 MB)
    • Transition period for Grandfathered and Gap medicines & determination of the MLP - December 10, 2020 (PDF 250 KB)
  • Public Webinar on the PMPRB Guidelines: November 20, 2020 (PDF 1.2 MB)
  • Guidelines consultation portal – Review the consultation process that led to the updated Guidelines, including feedback provided by stakeholders